InSEIT AG is a pioneering Contract Research Organisation (CRO) and manufacturer that specialises in enzyme immobilization technologies for the pharmaceutical industry. The company employs advanced bioinformatic tools and innovative screening technologies to develop customised immobilized biocatalysts tailored to specific reactions. Leveraging accumulated experience and a novel approach, InSEIT AG significantly reduces the development time, cost, and risk associated with immobilized enzymes, thus enhancing the overall efficiency and effectiveness of biocatalytic processes.

Services include:
- Biologics
- Development of tailored immobilized biocatalysts
- Application of bioinformatic tools
- Novel screening technologies

InSEIT AG is committed to providing cutting-edge solutions in the field of enzyme immobilization, helping clients unlock the full potential of biocatalysts. For more information, please visit inseit.ch.